Lymphoma is the eighth most common malignant tumor in China with a relatively high incidence rate. Moreover, there are generally two peaks in the age of onset, with the second peak occurring in elderly people around 60 years old. The probability ratio of male to female onset is generally 2.42-3.7:1, and the prognosis for women is better than that for men.
Lymphoma is a group of malignant tumors originating from lymph nodes or other lymphoid tissues, which can be divided into two categories: Hodgkin's disease (HD) and non Hodgkin's lymphoma (NHL). Histologically, tumor like proliferation of lymphocytes and/or tissue cells can be seen. Clinically, painless lymphadenopathy is the most typical, liver and spleen enlargement is common, and advanced stages include cachexia, fever, and anemia. The cell morphology of lymphoma is extremely complex, with 80 subtypes in the 2008 WHO new classification of lymphoma. Due to the different locations and scopes of lesions, clinical manifestations vary greatly. The primary site can be in lymph nodes or in lymph tissues outside the nodes, such as the tonsils, nasopharynx, gastrointestinal tract, spleen, bones, or skin. Primary lymphadenopathy is more common in NHL.
According to the World Health Organization's Pathological Classification of Lymphatic Tumors, there are currently nearly 70 known pathological types of lymphoma, which can be roughly divided into two categories: Hodgkin's lymphoma and non Hodgkin's lymphoma.
Hodgkin's lymphoma accounts for about 10% of lymphomas and is a relatively effective group of malignant tumors. It is divided into two categories, totaling five types, namely type 4 classical Hodgkin's lymphoma and nodular lymphocytic predominant Hodgkin's lymphoma.
In China, non Hodgkin's lymphoma accounts for about 90% of all lymphoma cases, and the incidence rate is increasing year by year. Non Hodgkin lymphoma is divided into two categories: B-cell type and T/NK cell type. So, how much does lymphoma treatment cost?
The main costs of treating lymphoma include examination fees and treatment fees. The laboratory tests for lymphoma diagnosis include serological examination, imaging examination, bone marrow examination, and biopsy. As PET/CT cannot be reimbursed by medical insurance in most provinces and cities, the initial diagnosis cost is expected to exceed 10000 yuan. The cost of subsequent treatment varies depending on the treatment plan and medication used.
Reducing the incidence of lymphoma can reduce the incidence rate of other malignant tumors by reducing environmental pollution, maintaining good living habits, treating some chronic inflammatory diseases of the body in time, improving the immunity of the body, and this is worthy of everyone's attention in daily life.
